Showing results (1741-1750 of 1,986) with videos related to

Sort By:
Pageof 199
Frontiers in Immunology|December 6, 2024
Modulation of the hepatic RANK-RANKL-OPG axis by combined C5 and CD14 inhibition in a long-term polytrauma modelYang Li, Klemens Horst, Johannes Greven, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Comparative Analysis of Molecular Pathogenic Mechanisms and Antiviral Development Targeting Old and New World HantavirusesArjit Vijey Jeyachandran, Joseph Ignatius Irudayam, Swati Dubey, et al.
Malaria Journal|April 12, 2020
Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysisJulie-Anne A Tangena, Chantal M J Hendriks, Maria Devine, et al.
Chest|December 20, 2025
Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM AssociationPatrick Flume, Wendy Bullington, Lily Christon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 1, 2019
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK InhibitorsJessica J Lin, Adam J Schoenfeld, Viola W Zhu, et al.
Foods (Basel, Switzerland)|January 17, 2024
Occurrence and Dietary Exposure of 3-MCPD Esters and Glycidyl Esters in Domestically and Commercially Prepared Food in SingaporeRaymond Rong Sheng Shi, Ping Shen, Wesley Zongrong Yu, et al.
Human Molecular Genetics|April 28, 2017
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosisNicole Ehrhardt, Michael E Doche, Shuang Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2015
Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKISamuel J Klempner, Lyudmila A Bazhenova, Fadi S Braiteh, et al.
Pageof 199